Intrinsic Value of S&P & Nasdaq Contact Us

Haleon plc HLN NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • GB • USD

SharesGrow Score
63/100
4/7 Pass
SharesGrow Intrinsic Value
$16.99
+75.2%
Analyst Price Target
$10.20
+5.2%

Stock Statistics — HLN

Haleon plc (HLN) has a market capitalization of $43.23B and trades at $9.70. The 52-week range is 8.71-11.42.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 26.9, Earnings Per Share (EPS) of $0.36, annual revenue of $10.79B.

The stock has a beta of 0.33, a last dividend of $0.1756, operates in the Healthcare sector.

Trading Data
Current Price$9.70
52-Week Range8.71-11.42
Volume4.53M
Avg Volume (30D)8.32M
Market Cap$43.23B
Beta (1Y)0.33
Last Dividend$0.1756
Company
IPO Date2022-07-25
Employees24,561
CEOBrian James McNamara
CountryGB
ExchangeNYSE
CurrencyUSD
ISINUS4055521003
CUSIP405552100
Income (Latest Year)
Revenue$10.79B
Gross Profit$6.99B
EBITDA$2.77B
Operating Income$2.42B
Net Income$1.63B
EPS$0.36
EPS Diluted$0.36
Shares Outstanding$4.48B
Balance Sheet (Latest Year)
Total Assets$32.57B
Current Assets$4.54B
Cash & ST Investments$1.32B
Total Liabilities$16.12B
Total Debt$8.59B
Net Debt$7.27B
Total Equity$16.46B
Debt / Equity0.52
Valuation Ratios
P/E Ratio26.9
P/S Ratio4.01
P/B Ratio2.63
EV/EBITDA (approx)15.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message